Pharmaceutical 282526-98-1 Cetilistat Weight Loss Cetilistat

• Customization: Available
• CAS No.: 282526-98-1
• Formula: C25h39no3
• Model NO.: QS-Cetilistat
• EINECS: 1308068-626-2
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: 2 Years
• Nutrient Composition: Cetilistat
• Resource: Cetilistat
• The content of active substances: 99%
• Product Name: Cetilistat
• Name: Cetilistat Powder
• Appearance: White Powder
• Colour: White
• Mf: C25h39no3
• MW: 401.591
• Density: 1.02
• Melting Point: 72.0
• Boiling Point: 509.7
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Lose Weight
• Specific: COA
• Test Method: HPLC
• Vp: 0mmhg at 25°c
• Transport Package: Negotiable
• Specification: 99%
• Trademark: QS
• Origin: Xi′an Shaanxi
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical 282526-98-1 Cetilistat Weight Loss Cetilistat

Product Description

Product Detials

Product Name	Cetilistat
Apperance	White powder
CAS	282526-98-1
MF	C25H39NO3
MW	401.59

Cetilistat (ATL-962), also known as cetilistat, is a new gastrointestinal lipase inhibitor developed by the British company Alizyme. Later, "Norgina BV" company obtained the global agency rights of "Cetilistat". Cetirix is undergoing Phase 3 clinical trials in the United States. In Japan, due to its cooperation with Takeda Pharmaceutical, Nelixostat was approved as a drug for the treatment of obesity in September 2013. The product name is "Oblean".

Application&Function

Application
Xinlixostat, also known as cetiristat, Celistat or cetiristat, is a white to white crystalline powder that is readily soluble in methanol. Its main uses include being a new type of weight loss drug and can also be applied to smoking cessation. Indications: New type of weight loss, smoking cessation, blood lipid lowering, pharmaceutical raw materials.

Drug effect
Xinlixostat is a long-acting and potent specific gastrointestinal lipase inhibitor. It exerts therapeutic effects by forming covalent bonds with the active serine sites of gastric lipase and pancreatic lipase in the stomach and small intestinal lumen, thereby inactivating the enzymes. The inactivated enzymes cannot hydrolyze the fats in food, mainly triglycerides, into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing calorie intake and controlling weight.

Specification

Certificate of Analysis